Association of presence of multiple APLA subtypes with thrombotic events; persistent versus persistent or transient antibodies
. | Persistent . | . | Persistent or transient . | . | ||
|---|---|---|---|---|---|---|
| Combination of APLA subtypes: IgG or IgM . | OR (95% CI) . | P . | OR (95% CI) . | P . | ||
| LA + ACLA | 29.4 (4.3-203) | .001 | 15.7 (2.6-96) | .003 | ||
| LA + anti-β2-GPI | 40.0 (5.3-299) | < .001 | 55.2 (5.5-556) | .001 | ||
| LA + anti-PT | 37.5 (3.1-449) | < .001 | 15.7 (2.6-96) | .003 | ||
| ACLA + anti-β2-GPI | 40.0 (5.3-299) | < .001 | 23.0 (3.5-156) | .001 | ||
| ACLA + anti-PT | 15.7 (2.6-96) | .003 | 8.1 (1.4-47) | .020 | ||
| anti-β2-GPI + anti-PT | 21.3 (3.2-142) | .002 | 10.3 (1.7-61) | .010 | ||
| LA + ACLA + anti-β2-GPI | 32.7 (4.2-256) | .001 | 29.4 (4.3-203) | .001 | ||
| LA + ACLA + anti-PT | 37.5 (3.1-449) | < .001 | 29.4 (4.3-203) | .001 | ||
| LA + anti-β2-GPI + anti-PT | 37.5 (3.1-449) | < .001 | 40.0 (5.3-299) | < .001 | ||
| ACLA + anti-β2-GPI + anti-PT | 32.7 (4.2-256) | .001 | 29.4 (4.3-203) | .001 | ||
| LA + ACLA + anti-β2-GPI + anti-PT | 37.5 (3.1-449) | < .001 | 40.0 (5.3-299) | < .001 | ||
. | Persistent . | . | Persistent or transient . | . | ||
|---|---|---|---|---|---|---|
| Combination of APLA subtypes: IgG or IgM . | OR (95% CI) . | P . | OR (95% CI) . | P . | ||
| LA + ACLA | 29.4 (4.3-203) | .001 | 15.7 (2.6-96) | .003 | ||
| LA + anti-β2-GPI | 40.0 (5.3-299) | < .001 | 55.2 (5.5-556) | .001 | ||
| LA + anti-PT | 37.5 (3.1-449) | < .001 | 15.7 (2.6-96) | .003 | ||
| ACLA + anti-β2-GPI | 40.0 (5.3-299) | < .001 | 23.0 (3.5-156) | .001 | ||
| ACLA + anti-PT | 15.7 (2.6-96) | .003 | 8.1 (1.4-47) | .020 | ||
| anti-β2-GPI + anti-PT | 21.3 (3.2-142) | .002 | 10.3 (1.7-61) | .010 | ||
| LA + ACLA + anti-β2-GPI | 32.7 (4.2-256) | .001 | 29.4 (4.3-203) | .001 | ||
| LA + ACLA + anti-PT | 37.5 (3.1-449) | < .001 | 29.4 (4.3-203) | .001 | ||
| LA + anti-β2-GPI + anti-PT | 37.5 (3.1-449) | < .001 | 40.0 (5.3-299) | < .001 | ||
| ACLA + anti-β2-GPI + anti-PT | 32.7 (4.2-256) | .001 | 29.4 (4.3-203) | .001 | ||
| LA + ACLA + anti-β2-GPI + anti-PT | 37.5 (3.1-449) | < .001 | 40.0 (5.3-299) | < .001 | ||